Mycophenolic acid induces adipocyte-like differentiation and reversal of malignancy of breast cancer cells partly through PPARγ

European Journal of Pharmacology

Volumn 658, Issue 1, 2011, Pages 1-8

  Zheng, Zhi Hui ^a,b,c   Yang, Yi ^b   Lu, Xin Hua ^c   Zhang, Hua ^c   Shui, Xiao Xi ^a   Liu, Chen ^a   He, Xiao Bo ^b   Jiang, Qin ^c   Zhao, Bao Hua ^a   Si, Shu Yi ^b  

^a HEBEI NORMAL UNIVERSITY   (China)

^b INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^c North China Pharmaceutical Corporation   (China)

Author keywords

Adipocyte differentiation; Breast cancer; Lipid accumulation; Mycophenolic acid; PPAR ; RNAi

Indexed keywords

ADIPSIN; ADIPSIN D; LIPID; LUCIFERASE; MYCOPHENOLIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RNA; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR GAL4; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL LEVEL; CELL PROLIFERATION; CELL VOLUME; CLONOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; RNA INTERFERENCE; TRANSCRIPTION INITIATION;

ADIPOCYTES; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; G0 PHASE; G1 PHASE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MYCOPHENOLIC ACID; PPAR GAMMA; TRANSCRIPTION, GENETIC;

EID: 79952816864     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.01.068     Document Type: Article

References (42)

1. A. Bardsley-Elliot, S. Noble, and R.H. Foster Mycophenolate mofetil: a review of its use in the management of solid organ transplantation Bio. Drugs 12 1999 363 410
2. J.F. Buell, T.G. Gross, and E.S. Woodle Malignancy after transplantation Transplantation 80 2005 s254 s264
3. R. Bullingham, S. Monroe, A. Nicholls, and M. Hale Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration J. Clin. Pharmacol. 36 1996 315 324 (Pubitemid 26125953)
4. F. Casadio, S. Croci, A. D'Errico Grigioni, B. Corti, W.F. Grigioni, L. Landuzzi, and P.L. Lollini Toward the definition of immunosuppressive regimens with antitumor activity Transplant. Proc. 37 2005 2144 2147 (Pubitemid 40956396)
5. T.H. Chang, and E. Szabo Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor γ in non-small cell lung cancer Cancer Res. 60 2000 1129 1138 (Pubitemid 30129556)
6. C.E. Clay, A.M. Namen, G. Atsumi, M.C. Willingham, K.P. High, T.E. Kute, A.J. Trimboli, A.N. Fonteh, P.A. Dawson, and F.H. Chilton Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells Carcinogenesis 20 1999 1905 1911 (Pubitemid 29476115)
7. R.G. Cohn, A. Mirkovich, B. Dunlap, P. Burton, S.H. Chiu, E. Eugui, and J.P. Caulfield Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines Transplantation 68 1999 411 418 (Pubitemid 29384110)
8. G.M. Danovitch Mycophenolate mofetil: a decade of clinical experience Transplantation 80 2005 s272 s275
9. G.D. Demetri, C.D. Fletcher, E. Mueller, P. Sarraf, R. Naujoks, N. Campbell, B.M. Spiegelman, and S. Singer Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma Proc. Natl Acad. Sci. USA 96 1999 3951 3956 (Pubitemid 29169017)
10. S. Domhan, S. Muschal, C. Schwager, C. Morath, U. Wirkner, W. Ansorge, C. Maercker, M. Zeier, P.E. Huber, and A. Abdollahi Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid Mol. Cancer Ther. 7 2008 1656 1668
11. T. Engl, J. Makarevic, B. Relja, I. Natsheh, I. Müller, W.D. Beecken, D. Jonas, and R.A. Blaheta Mycophenolate mofetil modulates adhesion receptors of the h1 integrin family on tumor cells: impact on tumor recurrence and malignancy BMC Cancer 5 2005 4
12. D. Floryk, and E. Huberman Mycophenolic acid-induced replication arrest, differentiation markers and cell death of androgen-independent prostate cancer cells DU145 Cancer Lett. 231 2006 20 29 (Pubitemid 41779449)
13. J. Folch, M. Sloane, and G.H. Stanley A simple method for the isolation and purification of total lipides from animal tissues J. Biol. Chem. 226 1957 497 509
14. S.R. Frankel, A. Eardley, G. Heller, E. Berman, W.H. Miller Jr., E. Dmitrovsky, and R.P. Warrell Jr. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study Ann. Intern. Med. 120 1994 278 286 (Pubitemid 24050023)
15. T.J. Franklin, and J.M. Cook The inhibition of nucleic acid synthesis by mycophenolic acid Biochem. J. 113 1969 515 524
16. A. Gortz, T.J. Franklin, C. Dive, and J.A. Hickman Cell cycle specific induction of HL-60 cell differentiation and apoptosis by mycophenolic acid Cell Death Differ. 4 1997 787 795 (Pubitemid 127680715)
17. Y.F. Guan, Y.H. Zhang, R.M. Breyer, L. Davis, and M.D. Breyer Expression of peroxisome proliferator-activated receptor γ (PPARgamma) in human transitional bladder cancer, and its role in inducing cell death Neoplasia 1 1999 330 339
18. S.A. Kliewer, K. Umesono, D.J. Noonan, R.A. Heyman, and R.M. Evans Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 358 1992 771 774
19. L. Kopelovich, J.R. Fay, R.I. Glazer, and J.A. Crowell Peroxisome proliferator-activated receptor modulators as potential chemopreventive agents Mol. Cancer Ther. 357 2002 357 363
20. T. Kubota, K. Koshizuka, E.A. Williamson, H. Asou, J.W. Said, S. Holden, I. Miyoshi, and H.P. Koeffler Ligand for peroxisome proliferator-activated receptor γ (troglitazone) has potent anti-tumor effect against human prostate cancer both in vitro, and in vivo Cancer Res. 58 1998 3344 3352 (Pubitemid 28371075)
21. M. Lefebvre, B. Paulweber, L. Fajas, J. Woods, C. McCrary, J.F. Colombel, J. Najib, J.C. Fruchart, C. Datz, H. Vidal, P. Desreumaux, and J. Auwerx Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells J. Endocrinol. 162 1999 331 340 (Pubitemid 29447426)
22. O.A. MacDougald, and M.D. Lane Transcriptional regulation of gene expression during adipocyte differentiation Annu. Rev. Biochem. 64 1995 345 373
23. G. Martinasso, M. Oraldi, A. Trombetta, M. Maggiora, o. Bertetto, R.A. Canuto, and G. Mizio Involvement of PPARs in cell proliferation and apoptosis in human colon cancer specimens and in normal and cancer cell lines PPAR Res. 2007 93416
24. E. Mueller, P. Sarraf, P. Tontonoz, R.M. Evans, K.J. Martin, M. Zhang, C. Fletcher, S. Singer, and B.M. Spiegelman Terminal differentiation of human breast cancer through PPARgamma Mol. Cell 1 1998 465 470 (Pubitemid 128378895)
25. N. Nakajima, N. Matsuura, M. Tsuruga, K. Takid, and J. Magae Mycophenolic acid as a latent agonist of PPARgamma Bioorg. Med. Chem. Lett. 17 2007 4767 4770 (Pubitemid 47193188)
26. Y. Ohsugi, S. Suzuki, and Y. Takagaki Antitumor and immunosuppressive effects of mycophenolic acid derivatives Cancer Res. 36 1976 2923 2927
27. D. Panigrahy, S. Huang, M.W. Kieran, and A. Kaipainen PPARγ as a therapeutic target for tumor angiogenesis and metastasis Cancer Biol. Ther. 4 2005 687 693 (Pubitemid 41351164)
28. K.W. Pankiewicz, K.B. Lesiak-Watanabe, and K.A. Watanabe Novel mycophenolic adenine bis (phosphonate) analogues as potential differentiation agents against human leukemia J. Med. Chem. 45 2002 703 712 (Pubitemid 34145717)
29. M. Saiki, Y. Hatta, T. Yamazaki, T. Itoh, Y. Enomoto, J. Takeuchi, U. Sawada, S. Aizawa, and T. Horie Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells Int. J. Oncol. 29 2006 437 443
30. P. Sarraf, E. Mueller, D. Jones, F.J. King, D.J. DeAngelo, J.B. Partridge, S.A. Holden, L.B. Chen, S. Singer, C. Fletcher, and B.M. Spiegelman Differentiation, and reversal of malignant changes in colon cancer through PPARgamma Nat. Med. 4 1998 1046 1052 (Pubitemid 28417337)
31. P. Sarraf, E. Mueller, W.M. Smith, H.M. Wright, J.B. Kum, L.A. Aaltonen, A. de la Chapelle, B.M. Spiegelman, and C. Eng Loss-of-function mutations in PPARgamma associated with human colon cancer Mol. Cell 3 1999 799 804 (Pubitemid 29323058)
32. Y. Sidi, C. Panet, L. Wasserman, A. Cyjon, A. Novogrodsky, and J. Nordenberg Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor Br. J. Cancer 58 1988 61 63
33. N. Suh, Y. Wang, C.R. Williams, R. Risingsong, T. Gilmer, T.M. Willson, and M.B. Sporn A new ligand for the peroxisome proliferator-activated receptor-γ (PPAR-γ), GW-7845, inhibits rat mammary carcinogens Cancer Res. 59 1999 5671 5673
34. S. Suzuki, T. Kimura, K. Ando, M. Sawada, and G. Tamura Antitumor activity of mycophenolic acid J. Antibiot. 22 1969 297 302
35. N. Takahashi, T. Okumura, W. Motomura, Y. Fujimoto, I. Kawabata, and Y. Kohgo Activation of PPARgamma inhibits cell growth, and induces apoptosis in human gastric cancer cells FEBS Lett. 455 1999 135 139 (Pubitemid 29322796)
36. N. Takebe, X.F. Cheng, T.E. Fandy, R.K. Srivastava, S.L. Wu, S. Shankar, K. Bauer, J. Shaughnessy, and G. Tricot IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells Mol. Cancer Ther. 5 2006 457 466
37. P. Tontonoz, E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman mPPAR-γ2: tissue-specific regulator of an adipocyte enhancer Genes Dev. 8 1994 1224 1234
38. P. Tontonoz, S. Singer, B.M. Forman, P. Sarraf, J.A. Fletcher, C.D. Fletcher, C.M. Fletcher, R.P. Brun, E. Mueller, S. Altiok, H. Oppenheim, R.M. Evans, and B.M. Spiegelman Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor Proc. Natl Acad. Sci. USA 94 1997 237 241 (Pubitemid 27027193)
39. R.J. Tressler, L.J. Garvin, and D.L. Slate Anti-tumor activity of mycophenolate mofetil against human and mouse tumors in vivo Int. J. Cancer 57 1994 568 573
40. M. Ubukata, H. Takamori, M. Ohashi, S. Mitsuhashi, K. Yamashita, T. Asada, Y. Tsubouchi, H. Sano, Y. Kawahito, S. Mukai, R. Yamada, M. Kohno, K. Inoue, T. Hla, and M. Kondo Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-γ agonists through induction of apoptosis Biochem. Biophys. Res. Commun. 270 2000 400 405 (Pubitemid 30446848)
41. T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs: from orphan receptors to drug discovery J. Med. Chem. 43 2000 527 550 (Pubitemid 30127149)
42. Z.H. Zheng, X.H. Lu, H. Zhang, G.P. Lv, J.G. He, B.H. Zhao, and S.Y. Si Impacts of different promoters on the mammalian one-hybrid assay for detecting nuclear receptor agonists Anal. Bioanal. Chem. 396 2010 1721 1730